BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29779306)

  • 1. [Surgical and comprehensive treatment for intrahepatic cholangiocarcinoma patients from the perspective of tumor heterogeneity].
    Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):328-331. PubMed ID: 29779306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viewpoint of systematic lymphadenectomy for intrahepatic cholangiocarcinoma patients].
    Lu W; Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):247-252. PubMed ID: 30929368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
    Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for intrahepatic cholangiocarcinoma.
    Hashimoto K; Miller CM
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):138-43. PubMed ID: 25214036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
    Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
    JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress on surgical treatment of intrahepatic cholangiocarcinoma].
    Shen F; Xie ZH; Xia Y; Wu MC
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):241-246. PubMed ID: 30929367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of intrahepatic cholangiocarcinoma in the USA.
    Lubezky N; Facciuto M; Harimoto N; Schwartz ME; Florman SS
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):124-30. PubMed ID: 25187408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrahepatic cholangiocarcinoma: proposal of new macroscopic classification].
    Yamamoto J; Kosuge T; Shimada K; Takayama T; Yamasaki S; Ozaki H; Makuuchi M
    Nihon Geka Gakkai Zasshi; 1993 Nov; 94(11):1194-200. PubMed ID: 8272051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for improving the prognosis of patients with intrahepatic cholangiocarcinoma by surgical treatment : Considerations based on experience and a literature review.
    Tashiro S; Tsuji T; Miyake H; Kamo H; Sumise Y; Takai S; Yoshioka K
    J Med Invest; 2021; 68(1.2):15-21. PubMed ID: 33994461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
    World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
    Seo N; Kim DY; Choi JY
    AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
    J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor.
    Oda E; Yamamura K; Hara Y; Matsumura K; Akahoshi S; Yuki H; Motohara T; Miyamoto H; Kinoshita K; Matsumura F; Ohnishi K; Komohara Y; Beppu T
    Anticancer Res; 2021 Oct; 41(10):5249-5254. PubMed ID: 34593478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.